SRGAP3-AS2
gene geneOn this page
Summary
SRGAP3-AS2 (SRGAP3 antisense RNA 2, HGNC:40899) is a long non-coding RNA gene on chromosome 3p25.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:40899 |
| Approved symbol | SRGAP3-AS2 |
| Name | SRGAP3 antisense RNA 2 |
| Location | 3p25.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000228723 |
| Ensembl biotype | lncRNA |
| Entrez | 101927416 |
| RNAcentral | URS000075C763 — lncRNA, 1310 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 lncRNA
ENST00000436032, ENST00000450920, ENST00000600323, ENST00000612302, ENST00000614304
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000436032 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001595000 | 9193429 | 9193490 |
| ENSE00001605141 | 9192493 | 9192995 |
| ENSE00004276593 | 9193726 | 9194453 |
Expression profiles
Bgee: expression breadth ubiquitous, 115 present calls, max score 98.52.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0504 / max 25.1158, expressed in 14 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 35198 | 0.0359 | 13 |
| 35200 | 0.0112 | 5 |
| 35199 | 0.0032 | 2 |
Top tissues by expression
205 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 98.52 | gold quality |
| bronchus | UBERON:0002185 | 96.77 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 89.93 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.40 | gold quality |
| right uterine tube | UBERON:0001302 | 89.16 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 81.51 | gold quality |
| endocervix | UBERON:0000458 | 77.08 | gold quality |
| right lung | UBERON:0002167 | 75.03 | gold quality |
| bone marrow cell | CL:0002092 | 74.16 | gold quality |
| fallopian tube | UBERON:0003889 | 73.07 | gold quality |
| oviduct epithelium | UBERON:0004804 | 72.37 | gold quality |
| endothelial cell | CL:0000115 | 68.07 | gold quality |
| adrenal tissue | UBERON:0018303 | 67.62 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 65.52 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 63.65 | gold quality |
| upper lobe of lung | UBERON:0008948 | 61.97 | gold quality |
| lung | UBERON:0002048 | 61.42 | gold quality |
| sural nerve | UBERON:0015488 | 60.76 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 59.36 | gold quality |
| left uterine tube | UBERON:0001303 | 59.13 | gold quality |
| corpus callosum | UBERON:0002336 | 57.85 | gold quality |
| uterine cervix | UBERON:0000002 | 56.52 | gold quality |
| trachea | UBERON:0003126 | 56.51 | silver quality |
| adrenal gland | UBERON:0002369 | 56.28 | gold quality |
| left adrenal gland | UBERON:0001234 | 55.56 | gold quality |
| right adrenal gland | UBERON:0001233 | 55.39 | gold quality |
| cerebellar vermis | UBERON:0004720 | 55.34 | gold quality |
| calcaneal tendon | UBERON:0003701 | 54.84 | gold quality |
| adrenal cortex | UBERON:0001235 | 53.48 | gold quality |
| tonsil | UBERON:0002372 | 53.45 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.